Related Experiment Video
Updated: Jul 29, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Oral calcium phosphate: a new therapy for Crigler-Najjar disease?
C N Van der Veere1, P L Jansen, M Sinaasappel
1Department of Gastrointestinal Diseases, Academic Medical Center, Amsterdam, The Netherlands.
Background & Aims:
Calcium phosphate binds unconjugated bilirubin in vitro, and dietary calcium phosphate supplementation reduces the serum bilirubin level in rats with hereditary unconjugated hyperbilirubinemia (Gunn rats). The aim of this study was to evaluate the effect of oral calcium phosphate supplementation on plasma bilirubin levels in patients with Crigler-Najjar disease.
Methods:
A placebo-controlled, double-blind, crossover design was used. Eleven patients, 2-42 years of age, participated. The group included 5 patients with type I disease who were all treated with phototherapy and 6 patients with type II disease who were primarily treated with phenobarbital. In addition to plasma bilirubin levels, dietary intake and urinary and fecal excretion of calcium and phosphate were evaluated.
Results:
A modest but significant decrease in serum bilirubin was observed in patients with type I disease (18% +/- 6%, P = 0.03) but not in patients with type II disease during treatment with calcium phosphate. Urinary output of calcium and phosphate did not change during the treatment period.
Conclusions:
Oral calcium phosphate may be a useful adjuvant to photo-therapy in Crigler-Najjar type I disease.
Related Concept Videos
Skeleton and Calcium Homeostasis
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease IV: Nursing Management

